<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02938247</url>
  </required_header>
  <id_info>
    <org_study_id>F3kc-002-CNI</org_study_id>
    <nct_id>NCT02938247</nct_id>
  </id_info>
  <brief_title>Tolerance and Compliance of a High Caloric, High Protein Oral Nutritional Supplement - Scheduled Intake</brief_title>
  <official_title>Prospective Tolerance and Compliance Study With a High Caloric, High Protein Oral Nutritional Supplement in Nursing Home Residents - Scheduled Intake</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fresenius Kabi</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fresenius Kabi</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to assess gastro-intestinal tolerance, palatability, compliance, and
      use of a high caloric, high protein oral nutritional supplement (ONS) in elderly people
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2016</start_date>
  <completion_date type="Actual">October 2016</completion_date>
  <primary_completion_date type="Actual">October 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Gastro-intestinal (GI) tolerance assessed by investigator (physical examination / presence of GI symptoms)</measure>
    <time_frame>At screening examination (study days -3 to -1)</time_frame>
    <description>The presence of the following GI symptoms will be documented: diarrhoea, constipation, bloating, distension, nausea, vomiting, burping, regurgitation, flatulence, abdominal discomfort, abdominal pain</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Gastro-intestinal (GI) tolerance assessed by investigator (physical examination / presence of GI symptoms)</measure>
    <time_frame>At end of study (study day 8)</time_frame>
    <description>The presence of the following GI symptoms will be documented: diarrhoea, constipation, bloating, distension, nausea, vomiting, burping, regurgitation, flatulence, abdominal discomfort, abdominal pain</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Gastro-intestinal (GI) tolerance assessed by subject (presence of GI symptoms assessed by subject's questionnaire)</measure>
    <time_frame>At study days 1-8</time_frame>
    <description>The presence of the following GI symptoms will be documented: diarrhoea, constipation, bloating, distension, nausea, vomiting, burping, regurgitation, flatulence, abdominal discomfort, abdominal pain</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Palatability of ONS (assessed by subject's questionnaire by using a 5-point hedonic-scale)</measure>
    <time_frame>At study days 1 and 7</time_frame>
    <description>Assessment of palatability (using a 5-point hedonic-scale) regarding appearance, smell, taste, sweetness, mouthfeel and product in general</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Compliance assessed by comparison of ONS amount prescribed vs. actual intake (in mL)</measure>
    <time_frame>At study days 1-7</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Compliance assessed by comparison of ONS amount prescribed vs. actual intake (in %)</measure>
    <time_frame>At study days 1-7</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Compliance assessed by percentage of subjects who reached ≥ 75% of prescribed dose of ONS</measure>
    <time_frame>At study days 1-7</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Use of ONS assessed by consumption</measure>
    <time_frame>At study days 1-7</time_frame>
    <description>Confirmation of consumption under supervision of study team</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Use of ONS assessed by presentation</measure>
    <time_frame>At study days 1-7</time_frame>
    <description>Confirmation of serving temperature</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reasons for non-compliance of ONS at a specific time of the day or on a specific day or for early termination (provided by subject by open question)</measure>
    <time_frame>At study days 1-7</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reasons for non-use of ONS at a specific time of the day or on a specific day or for early termination (provided by subject by open question)</measure>
    <time_frame>At study days 1-7</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Adverse Events</measure>
    <time_frame>At study days 1-8</time_frame>
  </other_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Malnutrition</condition>
  <arm_group>
    <arm_group_label>Single-arm study</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>High caloric, high protein ONS, three portions daily, total dose of 400 kcal/day for 7 consecutive days, oral administration</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>High caloric, high protein ONS</intervention_name>
    <arm_group_label>Single-arm study</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Sex: male/female

          2. Age: 65 years or older

          3. Body-mass index (BMI): ≥ 16.0 kg/m² and ≤ 30.0 kg/m²

          4. Subjects with an indication for ONS of approx. 400 kcal per day for at least 7 days

          5. Written informed consent

        Exclusion Criteria:

          1. Existing gastrointestinal diseases or pathological findings, which do not allow
             enteral nutrition

          2. Subjects with galactosaemia or similar metabolic disorders

          3. Subjects with severely impaired gastrointestinal function or complete failure

          4. Subjects with insulin-requiring diabetes

          5. Subjects with acute diarrhoea (defined as ≥ 3 loose or watery stools per day)

          6. Subjects reporting frequent occurrence of migraine attacks

          7. Subjects with acute or (current) chronic diseases, which might lead to impaired
             gustatory sense (e.g. sinusitis, anosmia)

          8. Existing mouth abnormalities, which cause impaired gustatory sense

          9. Subjects who report impaired gustatory sense (e.g. due to intake of concomitant
             medication)

         10. Subjects passing through chemotherapy (last cycle &lt; 2 months ago)

         11. Known allergic reactions or intolerance to any ingredient used or to constituents of
             the ONS

         12. Subjects with severe allergies or multiple drug allergies unless it is judged as not
             relevant for the clinical study by the investigator

         13. Consumption of any additional ONS, enteral nutrition via tube or parenteral nutrition

         14. Subjects with need of a special diet contradicting the intake of the ONS

         15. History of relevant central nervous system (CNS) and/or psychiatric disorders and/or
             currently treated CNS and/or psychiatric disorders

         16. Subjects with dysphagia or with high aspiration risk

         17. Enrolment in another clinical study

         18. Administration of any investigational medicinal product during the last month prior to
             individual enrolment of the subject

         19. Subjects who are not able to self-report GI-problems and compliance

         20. Subjects who report a general dislike of the ONS flavour

         21. Subjects for whom a hospitalisation for rehabilitation or surgery during the study is
             planned

         22. Subjects suspected or known not to follow instructions

         23. Subjects unable to understand the written and verbal instructions, in particular
             regarding the risks and inconveniences they will be exposed to during their
             participation in the clinical study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Cornelius Koch, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>SocraTec R&amp;D GmbH, Clinical Pharmacology Unit</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>SocraTec R&amp;D GmbH, Clinical Pharmacology Unit</name>
      <address>
        <city>Erfurt</city>
        <state>Thuringia</state>
        <zip>99084</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>October 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 12, 2016</study_first_submitted>
  <study_first_submitted_qc>October 17, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 19, 2016</study_first_posted>
  <last_update_submitted>October 19, 2016</last_update_submitted>
  <last_update_submitted_qc>October 19, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 20, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Malnutrition</keyword>
  <keyword>Geriatric subjects</keyword>
  <keyword>Nursing home</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Malnutrition</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

